BGB-A317-213
Completed
Study of Tislelizumab in Participants With Resectable Esophageal Squamous Cell Carcinoma
Study Overview
Sex:
All 
Age: 18 Years / N/A
Accepts Healthy Volunteers? yes
No Study Documents
Study Overview
Sex:
All
Age: 18 Years / N/A
Accepts Healthy Volunteers? yes
No Study Documents